Inc. looks at Walmart's employee drug coverage, which pays for the GLP-1 drugs while leaving out their use for weight loss.
Recap by typeshit. Full story at Inc.com.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Morse links out with a short warning to sellers about poking the bear. Thin on detail, so tap through for what prompted it.
BoxLife recaps the ranking: retatrutide gets B, BPC-157 low C, NAD+ D and epitalon F. Exercise is the only thing Nippard puts in S tier.
Loading…